🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CORONA Remedies Limited (NSE:CORONA)
India flag India · Delayed Price · Currency is INR
2,236.70
-19.50 (-0.86%)
At close: Nov 19, 2026

CORONA Remedies Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
15,59114,03211,96410,1458,8416,173
Revenue Growth
20.02%17.28%17.94%14.75%43.20%7.14%
Cost of Revenue
2,9552,7192,4312,3332,1561,495
Gross Profit
12,63611,3129,5337,8126,6854,678
Selling, General & Admin
5,5615,1024,5073,8573,3982,923
Other Operating Expenses
3,7253,2692,6192,3942,0041,576
Operating Expenses
9,7688,7517,4986,5345,6064,704
Operating Income
2,8682,5612,0351,2781,079-25.87
Interest Expense
-82.2-67-103.5-138.81-39.28-45.46
Interest & Investment Income
70.670.644.146.6559.7552.41
Earnings From Equity Investments
4.42.73.80.062.28-
Currency Exchange Gain (Loss)
24.124.16.74.875.624.25
Other Non Operating Income (Expenses)
19.96.53.81.47-1.285.71
EBT Excluding Unusual Items
2,9042,5981,9901,1921,106-8.96
Gain (Loss) on Sale of Investments
0.70.70.22.562.461.01
Gain (Loss) on Sale of Assets
-5.4-5.4-7.1-12.05-0.2-
Other Unusual Items
-189.1-189.11.91.930.56-
Pretax Income
2,7112,4041,9851,1851,109-7.95
Income Tax Expense
640.4553491279.78259.58-3.95
Net Income
2,0701,8511,494905.03849.29-4
Net Income to Common
2,0701,8511,494905.03849.29-4
Net Income Growth
18.27%23.88%65.11%6.56%--
Shares Outstanding (Basic)
616161615851
Shares Outstanding (Diluted)
616161615851
Shares Change
0.02%--4.89%14.21%-16.53%
EPS (Basic)
33.8530.2724.4314.8014.57-0.08
EPS (Diluted)
33.8530.2724.4314.8014.57-0.08
EPS Growth
18.27%23.90%65.09%1.59%--

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
608.2553.5988.3-1,29679.42636.98
Free Cash Flow Per Share
9.949.0516.16-21.191.3612.48
Dividend Per Share
-10.0007.3103.7002.7701.140
Dividend Growth
-36.80%97.57%33.57%142.98%-0.26%
Gross Margin
81.04%80.62%79.68%77.00%75.61%75.78%
Operating Margin
18.39%18.25%17.01%12.60%12.21%-0.42%
Profit Margin
13.28%13.19%12.49%8.92%9.61%-0.07%
Free Cash Flow Margin
3.90%3.94%8.26%-12.77%0.90%10.32%
EBITDA
3,3112,9032,3701,5261,251154.97
EBITDA Margin
21.24%20.69%19.81%15.04%14.15%2.51%
D&A For EBITDA
443.4341.6334.7247.4172.11180.84
EBIT
2,8682,5612,0351,2781,079-25.87
EBIT Margin
18.39%18.25%17.01%12.60%12.21%-0.42%
Effective Tax Rate
23.63%23.00%24.73%23.61%23.41%-
Revenue as Reported
15,71114,13812,02410,2098,9116,239
Advertising Expenses
-1,0721,045903.01850.41656.01